Risperdal Consta (risperidone)

Risperdal Consta (risperidone long‑acting injection)

Brand name: Risperdal® Consta®

Active ingredient: Risperidone

Type: Atypical antipsychotic

Available from: Janssen Inc.

Form: Long‑acting injection

Generic: No

Listed on Ontario formulary: Yes (with suggested criteria*)

OHIP+ coverage: Yes (with suggested criteria*)

*Suggested for individuals with non‑adherence and failure/side effects on:

• ≥2 oral antipsychotics including an atypical or
• ≥1 typical depot antipsychotic

Note: Oral tablets and solutions are also available as Risperdal®.

What is Risperdal Consta used for?

Used to treat schizophrenia and related psychotic illnesses in adults.
May also be used for bipolar disorder.

How should I take Risperdal Consta?

Injection given every 2 weeks by a healthcare provider.
Available as 12.5 mg, 25 mg, 37.5 mg, 50 mg vials.
Usual dose: 25 mg every 2 weeks, adjusted individually.

Common side effects

Same as oral Risperdal, plus:

• Injection‑site reactions

Rare but serious side effects

Same as oral Risperdal.

Warnings/Precautions

Not approved for dementia‑related psychosis.
Increased risk of cerebrovascular events in certain dementias.
Approved only for severe Alzheimer‑type dementia.

Medication interactions

Same interaction profile as oral Risperdal.

Avoid alcohol and illegal drugs.